| Literature DB >> 11315085 |
Abstract
A method for group sequential trials that is based on the inverse normal method for combining the results of the separate stages is proposed. Without exaggerating the Type I error rate, this method enables data-driven sample size reassessments during the course of the study. It uses the stopping boundaries of the classical group sequential tests. Furthermore, exact test procedures may be derived for a wide range of applications. The procedure is compared with the classical designs in terms of power and expected sample size.Mesh:
Substances:
Year: 1999 PMID: 11315085 DOI: 10.1111/j.0006-341x.1999.01286.x
Source DB: PubMed Journal: Biometrics ISSN: 0006-341X Impact factor: 2.571